Fathom Therapeutics
Uses quantum chemistry and AI to design novel drug molecules
$47MSeries A
Role not disclosedC
Chemistry
chemistry.vc ↗Activity from announced rounds
Activity in this selectionUnited States · Apr 30, 2026 · Apr 1, 2026
Chemistry backs early-stage founders combining technical expertise with commercial insight.
Investment approach
Its approach emphasizes working with founders from the beginning. The firm’s official site distinguishes current Chemistry investments from investments its partners made before the firm, keeping those track records separate.
Activity recorded by RoundOS
RoundOS records include Liquid Compute’s GPU-capacity marketplace and Wafer’s model-serving infrastructure. Assort Health, Fathom Therapeutics and Didero provide further examples in healthcare workflows, drug design and procurement software.
These examples describe financings recorded in RoundOS, rather than the investor’s complete portfolio.
Sources
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $47M 1 disclosed · full round size, not this investor’s share